Ahuva Schwartz, in Towson, MD - Speech-Language Pathologist

Ahuva Schwartz, is a Speech-language Pathologist based in Towson, Maryland. Ahuva Schwartz is licensed to practice in Maryland (license number 09292) and her current practice location is 6901 N Charles St, Towson, Maryland. She can be reached at her office (for appointments etc.) via phone at (443) 629-3909.

NPI number for Ahuva Schwartz is 1033672019 and her current mailing address is 6901 N Charles St, Towson, Maryland. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1033672019.

Contact Information

	Ahuva Schwartz,
	6901 N Charles St, Towson, MD 21204-3780
	(443) 629-3909
	Not Available

Healthcare Provider's Profile

Full Name	Ahuva Schwartz
Gender	Female
Speciality	Speech-language Pathologist
Location	6901 N Charles St, Towson, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1033672019
Provider Enumeration Date: 04/08/2019
Last Update Date: 12/20/2021

Medical Identifiers

Medical identifiers for Ahuva Schwartz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033672019	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	01689L (Maryland)	Secondary
235Z00000X	Speech-language Pathologist	09292 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Ahuva Schwartz is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Ahuva Schwartz, 6901 N Charles St, Towson, MD 21204-3780 Ph: () -	Ahuva Schwartz, 6901 N Charles St, Towson, MD 21204-3780 Ph: (443) 629-3909

News Archive

PharmaEssentia to present results of P1101 + ribavirin phase II trial in HCV patients at APASL 2016

PharmaEssentia Corporation announces presentation of the results of the phase II trial for P1101 + ribavirin in patients with chronic HCV genotype 1 infection at the 25th Conference of the Asian Pacific Association for the Study of the Liver, taking place in Tokyo, Japan from February 20 to 24, 2016 (APASL 2016). Data will be presented by the study coordinating investigator Prof. Wan-Long Chuang (Taiwan) at the HCV parallel oral session on Feb 22nd (15:45-17:45).

Report shows women affected by DCIS prefer nonsurgical treatments

When ductal carcinoma in situ (DCIS, a preinvasive malignancy of the breast) is described as a high-risk condition rather than cancer, more women report that they would opt for nonsurgical treatments, according to a research letter by Zehra B. Omer, B.A., of Massachusetts General Hospital—Institute for Technology Assessment, Boston, and colleagues.

Neurosurgical journals influence neurosurgeons and their patients

A compendium of articles in the Journal of Neurosurgery (JNS) provides evidence that specialty medical journals are not only an invaluable resource to physicians and researchers, but to the media and public. Clinical and basic science papers do not have to be published in large, high-impact publications to garner attention, and in fact when it comes to specialized areas of medicine such as neurosurgery, publications devoted to the subspecialty produce many citation classics. "Citation classic" is a term given to articles that have been cited more than 400 times.

Comparative effectiveness may not produce hoped-for savings, Study finds

One component of Democrats' health reform plan, comparative effectiveness research, would seek to improve quality and lower medical costs by identifying the most clinically and cost-effective treatments available, but a new study by the Rand Corp. finds the impact of the research may be slow to arrive, BusinessWeek reports.

AVEO to raise $61 million through private placement

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the execution of a securities purchase agreement with a select group of institutional and accredited investors providing for a private placement, or PIPE financing.

Speech-Language Pathologist in Towson, MD

Miss Victoria Diane Wank, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6501 N Charles St, Towson, MD 21204 Phone: 410-938-4411
Dr. Karen Anne Fallon, PH.D. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Olympic Place, Suite 200, Towson University Speech Language Hearing Center, Towson, MD 21204 Phone: 410-704-3095
Rebecca Noelle Heidenreich, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6901 N Charles St, Towson, MD 21204 Phone: 410-887-0919
Amy Gledhill, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8243 Pleasant Plains Rd, Towson, MD 21286 Phone: 410-615-4664
Katy T Reynolds, MSP CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 509 E Joppa Rd, Towson, MD 21286 Phone: 410-375-5163 Fax: 866-612-9084
Abigail Grimm, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6901 N Charles St, Towson, MD 21204 Phone: 443-809-4554
Mrs. Gail Dorothy Vanderbeek, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6901 N Charles St, Towson, MD 21204 Phone: 410-887-5121

Ahuva Schwartz, - Speech-Language Pathologist in Towson, MD